Home›Companies›Biotech & Pharma›Cytex Therapeutics

Cytex Therapeutics, Inc.

Updated Oct 29, 2026·Latest SEC filing Jan 10, 2025·Suggest an edit

About Cytex Therapeutics

Cytex Therapeutics is a private company based in Durham, North Carolina. It has reported $125,000 raised in one offering on Form D since January 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 27, 2024Jan 10, 2025$125,000of $2.0M target2$62,500Debt, OptionsRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cytex Therapeutics's Form D filed Jan 10, 2025.

CE
BE
Bradley Estes
Executive officer and director
FM
Franklin Moutos
Executive officer
FG
Farshid Guilak
Executive officer and director
DN
David Nolan
Director

Sources

  1. SECCytex Therapeutics, Inc. filing history